Adoptive transfer of genetically modified hematopoietic stem cells

Research output: Contribution to journalArticle

Abstract

Adoptive transfer of bone marrow derived blood forming stem cells is a well-recognized treatment option for some human genetic diseases. In this therapeutic approach a relatively small number of donor marrow cells engraft and proliferate extensively in the recipient. Arising blood cell progeny have the potential to provide the host with therapeutic levels of a desired gene product for at least two decades, quite possibly a lifetime. A long-standing challenge in human blood cell gene therapy has been progression from adoptive transfer of allogeneic stem cells which are inherently genetically 'correct', to adoptive transfer of autologous stem cells that have been specifically genetically 'corrected'. The progress in meeting this challenge will be reviewed. A promising approach for adoptive transfer of hematopoietic stem cells genetically modified in long-term marrow cultures will be presented and discussed.

Original languageEnglish (US)
Pages (from-to)137-145
Number of pages9
JournalTransfusion Science
Volume17
Issue number1
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Adoptive Transfer
Hematopoietic Stem Cells
Stem Cells
Bone Marrow
Blood Cells
Inborn Genetic Diseases
Medical Genetics
Cell- and Tissue-Based Therapy
Genetic Therapy
Therapeutics
Genes

ASJC Scopus subject areas

  • Immunology
  • Hematology

Cite this

Adoptive transfer of genetically modified hematopoietic stem cells. / Dubé, Ian D.; Stewart, Alexander Keith.

In: Transfusion Science, Vol. 17, No. 1, 1996, p. 137-145.

Research output: Contribution to journalArticle

@article{c2bff8028bf245d0ac471883536a1487,
title = "Adoptive transfer of genetically modified hematopoietic stem cells",
abstract = "Adoptive transfer of bone marrow derived blood forming stem cells is a well-recognized treatment option for some human genetic diseases. In this therapeutic approach a relatively small number of donor marrow cells engraft and proliferate extensively in the recipient. Arising blood cell progeny have the potential to provide the host with therapeutic levels of a desired gene product for at least two decades, quite possibly a lifetime. A long-standing challenge in human blood cell gene therapy has been progression from adoptive transfer of allogeneic stem cells which are inherently genetically 'correct', to adoptive transfer of autologous stem cells that have been specifically genetically 'corrected'. The progress in meeting this challenge will be reviewed. A promising approach for adoptive transfer of hematopoietic stem cells genetically modified in long-term marrow cultures will be presented and discussed.",
author = "Dub{\'e}, {Ian D.} and Stewart, {Alexander Keith}",
year = "1996",
doi = "10.1016/0955-3886(95)00067-4",
language = "English (US)",
volume = "17",
pages = "137--145",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Adoptive transfer of genetically modified hematopoietic stem cells

AU - Dubé, Ian D.

AU - Stewart, Alexander Keith

PY - 1996

Y1 - 1996

N2 - Adoptive transfer of bone marrow derived blood forming stem cells is a well-recognized treatment option for some human genetic diseases. In this therapeutic approach a relatively small number of donor marrow cells engraft and proliferate extensively in the recipient. Arising blood cell progeny have the potential to provide the host with therapeutic levels of a desired gene product for at least two decades, quite possibly a lifetime. A long-standing challenge in human blood cell gene therapy has been progression from adoptive transfer of allogeneic stem cells which are inherently genetically 'correct', to adoptive transfer of autologous stem cells that have been specifically genetically 'corrected'. The progress in meeting this challenge will be reviewed. A promising approach for adoptive transfer of hematopoietic stem cells genetically modified in long-term marrow cultures will be presented and discussed.

AB - Adoptive transfer of bone marrow derived blood forming stem cells is a well-recognized treatment option for some human genetic diseases. In this therapeutic approach a relatively small number of donor marrow cells engraft and proliferate extensively in the recipient. Arising blood cell progeny have the potential to provide the host with therapeutic levels of a desired gene product for at least two decades, quite possibly a lifetime. A long-standing challenge in human blood cell gene therapy has been progression from adoptive transfer of allogeneic stem cells which are inherently genetically 'correct', to adoptive transfer of autologous stem cells that have been specifically genetically 'corrected'. The progress in meeting this challenge will be reviewed. A promising approach for adoptive transfer of hematopoietic stem cells genetically modified in long-term marrow cultures will be presented and discussed.

UR - http://www.scopus.com/inward/record.url?scp=0029960860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029960860&partnerID=8YFLogxK

U2 - 10.1016/0955-3886(95)00067-4

DO - 10.1016/0955-3886(95)00067-4

M3 - Article

AN - SCOPUS:0029960860

VL - 17

SP - 137

EP - 145

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 1

ER -